AKT1 and pachyonychia congenita: The uncontrolled activation of the oncogenic kinase, Akt1 (encoded by AKT1), promotes pancreatic tumorigenesis and cancer progression; this kinase is a potential therapeutic target, and its expression levels and genetic polymorphisms are related to the survival, prognosis, and onset of cancer-associated disorders in patients with PC [64–69].